Haleon PLC (GB:HLN) has released an update.
Haleon PLC has announced the buyback and cancellation of 508,000 of its ordinary shares as part of its ongoing share repurchase program initiated in August 2024, with share prices ranging from 391.5 to 395.7 pence. This move reflects the company’s strategic efforts to manage its share capital, and shareholders may need to update their interest notifications accordingly. Haleon, a leader in consumer health products known for brands like Advil and Sensodyne, remains focused on promoting everyday health.
For further insights into GB:HLN stock, check out TipRanks’ Stock Analysis page.